本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ArTara Therapeutics, Inc.

3.62
-0.1300-3.47%
成交量:206.09萬
成交額:769.33萬
市值:2.14億
市盈率:-2.67
高:3.87
開:3.78
低:3.62
收:3.75
52周最高:7.82
52周最低:3.02
股本:5,909.55萬
流通股本:5,741.44萬
量比:3.53
換手率:3.59%
股息:- -
股息率:- -
每股收益(TTM):-1.3535
每股收益(LYR):-1.3409
淨資產收益率:-45.80%
總資產收益率:-28.82%
市淨率:1.33
市盈率(LYR):-2.70

資料載入中...

2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/05/20

SEC問詢函

Form CORRESP - Correspondence
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

重要事件披露

Form 8-K - Current report
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities